Hurth, A.; Nijzink-Ter Steege, J.; Scheepbouwer, P.; Roose, E.; Lahousse, A.; Leysen, L.; Stas, L.; Kregel, J.; Salvat, E.; Nijs, J.
Assessment of Central Sensitization in Breast Cancer Survivors: Convergent Validity and Use of the Central Sensitization Inventory (CSI) and Its Short-Form as a Clustering Tool. Clin. Pract. 2021, 11, 607-618.
https://doi.org/10.3390/clinpract11030076
AMA Style
Hurth A, Nijzink-Ter Steege J, Scheepbouwer P, Roose E, Lahousse A, Leysen L, Stas L, Kregel J, Salvat E, Nijs J.
Assessment of Central Sensitization in Breast Cancer Survivors: Convergent Validity and Use of the Central Sensitization Inventory (CSI) and Its Short-Form as a Clustering Tool. Clinics and Practice. 2021; 11(3):607-618.
https://doi.org/10.3390/clinpract11030076
Chicago/Turabian Style
Hurth, Alban, Jessica Nijzink-Ter Steege, Pauline Scheepbouwer, Eva Roose, Astrid Lahousse, Laurence Leysen, Lara Stas, Jeroen Kregel, Eric Salvat, and Jo Nijs.
2021. "Assessment of Central Sensitization in Breast Cancer Survivors: Convergent Validity and Use of the Central Sensitization Inventory (CSI) and Its Short-Form as a Clustering Tool" Clinics and Practice 11, no. 3: 607-618.
https://doi.org/10.3390/clinpract11030076
APA Style
Hurth, A., Nijzink-Ter Steege, J., Scheepbouwer, P., Roose, E., Lahousse, A., Leysen, L., Stas, L., Kregel, J., Salvat, E., & Nijs, J.
(2021). Assessment of Central Sensitization in Breast Cancer Survivors: Convergent Validity and Use of the Central Sensitization Inventory (CSI) and Its Short-Form as a Clustering Tool. Clinics and Practice, 11(3), 607-618.
https://doi.org/10.3390/clinpract11030076
